Tilray | TRLY - Lieferungen Und Leistungen

Aktienkurs
7.56
Täglich Wechseln
-0.07 -0.92%
Monatlich
-18.36%
Jährlich
1,081.25%
Q2 Prognose
7.47




Lieferungen Und Leistungen Veränderung Datum
Acasti Pharma USD 20K 0 2025-09
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Avita Medical AUD 9.11M 2.26M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Cronos Group USD 73.17M 4.87M 2026-03
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Ionis Pharmaceuticals USD 74M 8M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Moderna USD 71M 113M 2026-03
Organigram Holdings CAD 49.94M 14.92M 2025-12
Organon & Co USD 1.33B 153M 2025-12
Revvity USD 691.38M 53.29M 2026-03
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.08B 45M 2026-03
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12